ArticleCancer research communications2023

Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers.

Taraswi Mitra Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.